Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of intra-articular tranexamic acid for reduction of total blood loss in total hip arthroplasty
2020-003321-32Phase 2Active
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in None comparing Intravenous + intra-articular tranexamic acid with Intravenous tranexamic acid + intra-articular placebo (NaCl) (2 arms). Primary endpoint: Total blood loss at 24 hours after surgery. Started Jul 2020; status: active.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on 2020-003321-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003321-32.